A review abstract presented in the on-line version of the June 2009 British Journal of Ophthalmology addressed dietary information collected on 2,924 AREDs subjects during the 8-year trial period.
Biosyntrx, in concert with ophthalmologists, optometrists, PhD biochemists, molecular biologists, and nutrition educators, develops evidence-based nutraceutical formulations that support optimal health - specifically the exquisitely engineered functions of the eyes, which reveal some of the earliest signs of degeneration affecting the entire body. Biosyntrx formulations are designed to address the micronutrient needs of the dry eye, cataract, macula degeneration, glaucoma and diabetic retinopathy patient. Nutrients, which have been proven to be good for the eyes, have also been proven good for the entire body.
Clinical Study Review: A Biosyntrx Editorial
The biochemistry and molecular biology genome science associated with retinal health, and particularly macular degeneration, suggests a strong connection between dietary intake, gene regulation, and disease prevention and progression.
